Ketek News
Most Popular Ketek Story
FDA criticizes Aventis for Ketek study failures
Aventis allowed a clinical trial of Ketek to proceed uncorrected despite its own audits that revealed "serious protocol violations and regulatory noncompliance by multiple clinical Read more...
Latest Headlines
- October 25, 2007
- December 17, 2006
- December 7, 2006
- November 30, 2006
- September 12, 2006
- June 29, 2006
- June 20, 2006
- June 14, 2006
- June 11, 2006
- May 18, 2006
- May 1, 2006
- April 30, 2006
- January 19, 2006
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
